LOS ANGELES — De Novo Software™, a leading provider of flow and image cytometry data analysis solutions, and Nexcelom Bioscience, a leading supplier of cell counting and analysis products for bioresearch and drug discovery, announced today a licensing agreement enabling Nexcelom to distribute De Novo Software’s flagship product, FCS Express 4 Software.

Under the terms of the agreement, Nexcelom will distribute the FCS Express 4 Cytometry Software to customers in the research, biotech and pharmaceutical markets worldwide. The FCS Express 4 Software can natively import Nexcelom Cellometer® Vision data for visualization of multi-parametric results.

With the Cellometer Vision CBA Analysis System, a drop-down menu of assays with pre-set optical module selection, exposure time, and data calculation/presentation set-up make imaging and analysis simple and repeatable. With just 20 Microlitres of sample and a few clicks, users obtain fluorescent cell images, dot plots, and histograms in pre-optimized layouts for specific cell-based assays. Researchers can view cell morphology real-time and archive cell images along with comprehensive analysis reports.

According to Jean Qiu, CTO at Nexcelom, “FCS Express 4 is helping us to improve the overall end-user experience, enabling scientists to focus less on the plotting and formatting process and more on results. We are excited to offer a simple, microscopy-based platform for cell-based assays as an alternative to more complex fluidic instruments.”

De Novo Software launched FCS Express 4 in January of 2011. In addition to fully customized analysis and reporting, the new software adds the ability to analyze image based data. These novel tools significantly improve assay development, workflow, and enable rapid report generation with image based assays.

David Novo, De Novo Software’s president said: “This is an exciting collaboration and business relationship. We look forward to providing options for flexible data analysis and reporting platform for the Nexcelom Cellometer® Vision customers.”

Peter Li, CEO at Nexcelom said: “Seamless integration of FCS Express 4 provides state-of-the-art data reporting and applications support for the Cellometer cell based assays. De Novo Software is a key strategic partner in our continued effort to provide total solutions to simplify current work flows for our customers.”

Michael Sjaastad, Director of Business Development at De Novo Software commented, “There is an unmet need for a common analysis platform for all cytometry data. We look forward to building upon this key relationship to provide a general platform for data analysis and report generation used by scientists worldwide.”